Form 4 for GILD Gilead Sciences
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-10 · accession 0001127602-22-009273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-15 | 2022-03-10 | GILD | Dickinson Andrew D | CFO | M - OptEx | — | +7,901 | 63.5K | +14% | — |
| D | 2022-03-15 | 2022-03-10 | GILD | Dickinson Andrew D | CFO | F - Tax | $57.92 | -3,602 | 64.0K | -5% | -$208.6K |
| DM | 2022-03-15 | 2022-03-10 | GILD | Dickinson Andrew D | CFO | M - OptEx | — | -7,901 | 27.7K | -22% | — |
| DM | 2022-03-15 | 2022-03-10 | GILD | Dickinson Andrew D | CFO | A - Grant | $0.00 | +182.5K | 53.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 768 | — | 60,474 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2022-03-10 | M | A | 4,108 | — | 67,607 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Common | Common Stock | 2022-03-10 | M | A | 3,025 | — | 63,499 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 4 | Common | Common Stock | 2022-03-10 | F | D | 3,602 | $57.92 | 64,005 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 768 | — | 34,792 | D | — · — to — | 768 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-03-10 | A | A | 157,030 | $0.00 | 157,030 | D | $57.92 · — to 2032-03-10 | 157,030 Common Stock | (F4) The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 7 | Derivative | Restricted Stock Unit | 2022-03-10 | A | A | 25,465 | — | 53,124 | D | — · — to — | 25,465 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 8 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 3,025 | — | 31,767 | D | — · — to — | 3,025 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |
| 9 | Derivative | Restricted Stock Unit | 2022-03-10 | M | D | 4,108 | — | 27,659 | D | — · — to — | 4,108 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |